Patent · US Active

Compositions and methods for modulating Factor IX function

US11708570B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2017
Grant dateJul 25, 2023
Priority date—
Expiry dateMar 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/21022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor IX/IXa variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.